Myasthenia gravis during interferon alfa therapy

Autor:	M.T. Palmisani, F. Apollo, Amelia Evoli, Serenella Servidei, Anna Paola Batocchi, Pietro Attilio Tonali
Jazyk:	angličtina
Rok vydání:	1995
Předmět:	Male medicine.medical_treatment Muscle Fibers Skeletal Alpha interferon Cytochrome-c Oxidase Deficiency Interferon alpha-2 Electron Transport Complex IV Interferon Myasthenia Gravis medicine Humans Interferon alfa Chemotherapy Muscle biopsy medicine.diagnostic_test business.industry Electromyography Lymphoma Non-Hodgkin Autoantibody Interferon-alpha Middle Aged medicine.disease Myasthenia gravis Recombinant Proteins Lymphoma Succinate Dehydrogenase Settore MED/26 - NEUROLOGIA Urinary Bladder Neoplasms Immunology Neurology (clinical) business medicine.drug
Popis:	Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies. One of these patients had myopathic findings on EMG and focal deficiency of cytochrome c oxidase on muscle biopsy.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b55d308143be5d3bc34122df47007591 http://hdl.handle.net/10807/19016 Zobrazit plný text záznamu